NCT05429866 2023-03-08Immunological Variables Associated to ICI Toxicity in Cancer PatientsJules Bordet InstitutePhase 2 Unknown441 enrolled
NCT03734913 2020-07-22A Phase 1 Study of ZSP1602 in Participants With Advanced Solid TumorsGuangdong Zhongsheng Pharmaceutical Co., Ltd.Phase 1 Unknown65 enrolled
NCT03544723 2020-06-09Safety and Efficacy of p53 Gene Therapy Combined With Immune Checkpoint Inhibitors in Solid Tumors.MultiVir, Inc.Phase 2 Unknown40 enrolled